PCP
HOLX

Perbak Capital Partners’s Hologic HOLX Stock Holding History

Perbak Capital Partners’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,694
Closed -$1.4M – 273
2025
Q3 		$1.4M Buy
20,694
+10,548
+104% +$700K 0.25% 39
2025
Q2 		$661K Buy
+10,146
New +$608K 0.15% 144

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Perbak Capital Partners's HOLX Position: Q4 2025 in Review

Perbak Capital Partners sold out of Hologic (HOLX) in Q4 2025, closing a stake of 20,694 shares — an estimated $1.4M sold.

Perbak Capital Partners first reported a position in HOLX in Q2 2025 and held it in 2 quarters. The position peaked at $1.4M in Q3 2025. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Perbak Capital Partners reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Perbak Capital Partners sold 20,694 Hologic shares in Q4 2025, an estimated $1.4M.
  • Perbak Capital Partners first reported a position in Hologic in Q2 2025 and held it in 2 quarters.
  • Perbak Capital Partners's Hologic position peaked at $1.4M in Q3 2025.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Perbak Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.